Search

The page you requested does not exist. For your convenience, a search was performed using the query story.
Filter:
Did you mean
stock

Search Results

Clarus raises $500M life sci fund; Smart glucose monitor contact lens maker among Thiel Fellows;

at its Agila plants in India. FiercePharmaManufacturing story | Follow @EricPFierce @CarlyHFierce: Could ...

CDC suggests link between Opana and HIV outbreak; NICE gives final nod to Xolair for hives;

infusion set featuring enhanced insulin delivery. Story | Follow @VarunSaxena2 > Medtronic launches bariatric surgery tool to enable more consistent procedures. Story > Outset Medical rounds up $91M ...

AC Immune weighs an IPO; Novartis plays catch-up in PD-1;

FiercePharmaManufacturing  story  | Follow  @EricPFierce @CarlyHFierce:  Could an $18.9B Shire bid convince Actelion to ditch ...

GSK-linked private eye released early from Chinese prison

the FT story Special Report: Top 10 drugmakers in emerging markets- GSK Related Articles: GSK's ...

Pfizer scientist warned execs about Zoloft and birth defects, lawyers say

reuptake inhibitors, or SSRIs.- read the Bloomberg story Related Articles: Pfizer prevails in first court ...

U.S. poised to spend $50B on just 10 'breakthrough' meds in 10 years

and consumer premiums," the report noted.- get the Avalere report (PDF)- see the MedPage Today story ...

Australia's Proteomics claims first predictive diabetic kidney disease diagnostic test

here's the release  (PDF) from Proteomics International and a story from The Australian (sub. req.) ...

South Korea's MERS outbreak raises SARS-like regional health response

of passengers.- here are stories from the Korea Herald and Xinhua Related Articles: China says papers on MERS ...

Cordis launches two new catheters; Cerebain raises $2M for dementia device;

Story | Follow @EmilyWFierce > Omada Health, a digital health company that employs connected scales, pedometers and devices in employer-based wellness programs, was featured in Bloomberg. Story > Johnson ...

Top Novartis brass backs results-based drug pricing

run."- get the Tages-Anzeiger piece- read the FT story Special Reports: Top 15 pharma companies by 2014 ...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »